2006Zhongguo kangganran hualiao zazhiRequires access

Antimicrobial resistance of Mycoplasma infection in outpatients of gynecology

Wan Xiong-pin

Open publisher page 0 citations

Abstract

ObjectiveTo investigate the antimicrobial resistance of Ureaplasma urealyticum(Uu) and Mycoplasma homonis(Mh) isolated from outpatients in our hospital from 2003 to 2004.MethodsThe test kit Mycoplasma IST 2 of BioMerieux was used for identification,and susceptibility testing of Uu and Mh isolates.ResultsUu,Mh and Uu+Mh co-infection were identified from 44.8%(284/634),0.6%(4/634) and 9.5%(60/634) of 634 clinical specimens,respectively.The Uu isolates were least resistant to josamycin(0.4%),but highly resistant to ofloxacin(31.7%) and ciprofloxacin(61.3%).The prevalence of Mycoplasma infection was similar between year 2003 and 2004.It was 57.4%(112/195) and 53.8%(236/439) respectively.Uu+Mh co-infection slightly increased from 10.7%(12/112) in 2003 to 20.3%(48/236) in 2004.ConclusionsUu is one of the key pathogens causing infections in women.The resistance of Mycoplasma is serious.Antimicrobial therapy should be rationally used in order to delay the emergence of resistant strain.

About this research paper

What this paper is about

ObjectiveTo investigate the antimicrobial resistance of Ureaplasma urealyticum(Uu) and Mycoplasma homonis(Mh) isolated from outpatients in our hospital from 2003 to 2004.MethodsThe test kit Mycoplasma IST 2 of BioMerieux was used for identification,and susceptibility testing of Uu and Mh isolates.ResultsUu,Mh and Uu+Mh co-infection were identified from 44.8%(284/634),0.6%(4/634) and 9.5%(60/634) of 634 clinical specimens,respectively.The Uu isolates were least resistant to josamycin(0.4%),but highly resistant to ofloxacin(31.7%) and ciprofloxacin(61.3%).The prevalence of Mycoplasma infection was similar between year 2003 and 2004.It was 57.4%(112/195) and 53.8%(236/439) respectively.Uu+Mh co-infection slightly increased from 10.7%(12/112) in 2003 to 20.3%(48/236) in 2004.ConclusionsUu is one of the key pathogens causing infections in women.The resistance of Mycoplasma is serious.Antimicrobial therapy should be rationally used in order to delay the emergence of resistant strain.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

ObjectiveTo investigate the antimicrobial resistance of Ureaplasma urealyticum(Uu) and Mycoplasma homonis(Mh) isolated from outpatients in our hospital from 2003 to 2004.MethodsThe test kit Mycoplasma IST 2 of BioMerieux was used for identification,and susceptibility testing of Uu and Mh isolates.ResultsUu,Mh and Uu+Mh co-infection were identified from 44.8%(284/634),0.6%(4/634) and 9.5%(60/634) of 634 clinical specimens,respectively.The Uu isolates were least resistant to josamycin(0.4%),but highly resistant to ofloxacin(31.7%) and ciprofloxacin(61.3%).The prevalence of Mycoplasma infection was similar between year 2003 and 2004.It was 57.4%(112/195) and 53.8%(236/439) respectively.Uu+Mh co-infection slightly increased from 10.7%(12/112) in 2003 to 20.3%(48/236) in 2004.ConclusionsUu is one of the key pathogens causing infections in women.The resistance of Mycoplasma is serious.Antimicrobial therapy should be rationally used in order to delay the emergence of resistant strain.

Key concepts: Josamycin, Ureaplasma urealyticum, Mycoplasma, Ofloxacin, Microbiology, Ciprofloxacin, Antimicrobial, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Antimicrobial resistance of Mycoplasma infection in outpatients of gynecology — Research Paper | ScholarLens